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Abstract: Objective: The present study aimed to investigate how far supplementation of dietary omega-3 fatty acids 
could affect endothelial dysfunction and augment elevation of Asymmetric Dimethylarginine (ADMA) in experimental 
diabetes. 
Methods: To fulfill our objective, forty male albino rats were divided into four experimental groups as follow: Control, 
flaxseed oil, diabetic, and treated flaxseed oil groups. After blood sample collection from all groups, plasma was used for 
estimation of different biochemical parameters including blood glucose and plasma insulin. The levels of liver 
malondialdehyde (MDA), liver superoxide dismutase (SOD) and plasma nitric oxide (NO) were determined by 
colorimetric methods. ADMA was estimated by HPLC using fluorescence detector. 
Results: Streptozotocin (STZ) induced experimental diabetes was shown by the significant elevation in blood glucose 
levels, insulin resistance and oxidative stress as revealed by a significant increase in the levels of liver MDA 
accompanied with a significant reduction in SOD activity. In addition, STZ administration significantly elevated ADMA 
level. In contrast, flaxseed oil supplementation was capable of ameliorating these negative changes in STZ injected rats. 
Conclusion: Dietary omega-3 fatty acids present in flaxseed oil can ameliorate endothelial dysfunction and elevation of 
ADMA in STZ induced diabetes. These results could be assigned to the potential antioxidant, anti-apoptotic, and anti-
inflammatory effects of flaxseed oil. 
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INTRODUCTION 
Diabetes mellitus (DM) is a complicated disease 
associated with hyperglycemia, impaired insulin 
production and /or declined insulin action causing the 
disability of glucose molecules to be transported from 
blood to peripheral tissues resulting in elevation of 
blood sugar and urinary glucose excretion [1]. This 
process is characterized by impaired synthesis and 
also bioavailability of the vasodilator factor (NO) [2]. 
Moreover, nitric oxide helps in platelet accumulation 
inhibition, leucocytes immigration cellular adhesion, 
and the proliferation of vascular smooth muscle in 
addition to the providing of vascular homeostasis, the 
main and the very important action of nitric oxide [3, 4]. 
Thus, it was observed that endothelial dysfunction 
starts when nitric oxide decreases [5]. 
Endothelial cells synthesized ADMA which is 
released in sufficient amounts and are capable of 
inhibiting NO production [6, 7], where it contributes as a 
key molecule to endothelial dysfunction. Also Elevated 
levels of plasma ADMA are seen in patients with 
chronic heart failure, in hypertensive and 
hypercholesterolemic patients, and in other patient 
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groups at high risk of developing cardiovascular 
disease. 
Great interest was concentrated on the relation 
between diabetic complications and the quantity as well 
as quality of dietary lipids [8]. It was observed that 
increased omega-3 fatty acids enhanced insulin 
sensitivity in adipocytes of sucrose-fed rats [9].  
Thus, this study aimed to evaluate how far 
supplementation of dietary omega-3 fatty acids could 
affect endothelial dysfunction and diminish elevation of 
ADMA in experimental diabetes.  
MATERIALS AND METHODS 
Materials 
Streptozotocin (STZ), ADMA (HPLC standard), 
tetrahydrofuran (THF), O-Phthaldialdehyde (OPA) and 
mercaptoethanol were purchased from Sigma Aldrich 
Company St. Louis USA. 
Experimental Animals 
Male albino rats with average weight between 180-
200 g were obtained from the animal house of National 
Research Centre, Giza, Egypt. They were housed 
individually in suspended stainless steel cages in a 
suitable environment (22-25°c) with 12 hour light, 12 
hour dark. Animals had sustained access to standard 
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rodent chow diet and water. The experimental animals 
received human care in accordance to guidelines of the 
Ethical Committee of National Research Centre, Egypt 
and followed the recommendations of the National 
Institutes of Health Guide for Care and Use of 
Laboratory Animals. 
Methods 
Induction of Diabetes 
Sodium citrate (50 mM and pH 4.5) solution 
containing 150 mM NaCl was used to dissolve 
streptozotocin. The solution containing (6.0 mg/100g 
body weight) was administrated s.c. in rats; fasting 
blood glucose was measured after 72 hours to confirm 
diabetes mellitus development [10]. 
Experimental Design 
Forty male albino rats were used in this study and 
divided into four groups (ten rats each) as follows: 
Group I (control): Normal rats received a vehicle. 
Group II (flaxseed oil): Normal rats received 
flaxseed oil (1.2 ml / kg b.w. / day) orally. 
Group III (diabetic): Diabetic induced rats received a 
vehicle. 
Group IV (treated): Diabetic induced rats received 
flaxseed oil (1.2 ml / kg b.w. / day) orally [1]. 
After the experimental period (4 weeks); blood 
withdrawn was done using capillary tubes from the 
orbital vein and collected in a- tubes containing sodium 
fluoride for blood sugar measurement and b- test tubes 
contain anticoagulant for other different biochemical 
analysis. 
Liver was quickly removed and placed in iced 
normal saline, perfused with normal saline solution to 
remove blood cells, blotted on filter paper and frozen at 
-80°C. The frozen tissues were cut into small pieces 
and homogenized in 5 ml buffer (0.7 g of NaH2PO4 and 
0.5 g of Na2HPO4) in 500 ml deionized water (pH: 7.4) 
/ gram tissue; centrifuged at 4000 rpm for 15 min. at 
4°C, the supernatant was kept for estimation of 
oxidant/antioxidant parameters [11]. 
Fasting blood glucose was measured by 
colorimetric method using commercial kit from Vitro 
Scient, Egypt, based on the previous method [12]. 
Oxidant/antioxidant parameters were estimated by 
commercial kits; liver MDA [13] SOD [14] and plasma 
NO [15] were measured colorimetrically according to 
the methods described previously. All kits were 
purchased from Bio. Med. Diagnostics. 
Plasma insulin level was estimated by ELISA 
according to Yalow and Bauman [16] using BioSoure 
INS-EASIA Kit. Insulin resistance was calculated from 
the equation: 
Insulin resistance = fasting glucose (mg dl–1) X 
fasting insulin (µIU ml–1)/405 [17]. 
Determination of ADMA by High Performance 
Liquid Chromatography 
ADMA was assayed by modified HPLC method as 
described previously [18]. 
Sample Preparation 
Twenty-five mg from 5-sulfosalicylic acid (5-SSA) 
were added to 1 mL plasma, mixed well then left for10 
min. in an ice-bath; the precipitated protein was 
removed by centrifugation at 4000 r.p.m. using cooling 
centrifuge (Laborzentrifugen, 2K15, Sigma, Germany) 
for 10 min., the supernatant was filtered through 
hydrophilic PVDF 0.45 µm filter; then mix 50 µL from 
the filtered solution with 500 µL of OPA solution and 
left for 3 min. before injecting into HPLC. 
HPLC Condition 
Ten µl of (sample-OPA) were injected onto HPLC; 
separation was achieved on C18 column (150 X 4.6 
mm). The mobile phase consisted of sodium acetate 
buffer / methanol / THF with a ratio (A, 82:17:1and B, 
22:77:1, % v, respectively) and eluted in a flow rate 1.0 
ml/min. by gradient method as shown in Table 1. 
Column temperature was adjusted at 37°C and a 
fluorescence detector was set at 338 nm excitation and 
425 nm emissions. A linear standard curve was 
constructed by plotting peak areas versus the 
corresponding concentration in each diluted standard. 
The concentration in samples was obtained from the 
standard curve. 
Table 1: Mobile Phase A and B Percent 
Time (min) Percent of A Percent of B 
0.00 – 4.90 100 00 
5.00- 14.99 90 10 
15.00-24.99 60 40 
25.00-27.99 25 75 
28.00-32.00 10 90 
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STATISTICAL ANALYSIS 
Results were representing as mean ± standard error 
(SE). Data were analyzed by SPSS (version 15). 
Differences between groups were considered 
significant when P value <0.05. 
RESULTS 
Here, the mean values of fasting blood sugar, 
insulin level and insulin resistance were insignificantly 
changed in flaxseed oil group when compared to 
control confirming the safety of flaxseed oil. Whereas, 
in diabetic rats, fasting blood sugar was significantly 
increased along with a reduction in insulin level 
resulting in a significant increase in insulin resistance 
compared to control one. Contrarily, flaxseed oil 
administration significantly improved these parameters 
in treated group compared to diabetic one (Table 2). 
STZ injection significantly increased oxidative stress 
in diabetic group compared to control which was 
appeared by the elevation of lipid peroxidation and the 
reduction of antioxidant enzyme (SOD) activity. 
However, flaxseed oil significantly decreased MDA and 
increased the activity of SOD in treated rats compared 
to diabetic (Table 3).  
In addition, ADMA level was significantly increased 
in diabetic group along with a significant reduction in 
NO level compared to control group. Whereas, 
flaxseed oil supplementation significantly increased NO 
and significantly decreased ADMA level in treated 
group compared to diabetic group (Table 4). 
DISCUSSION  
Here, the elevation of fasting blood sugar in diabetic 
group may be resulting from ß-cells destruction 
following streptozotocin injection [19]. Therefore, in 
streptozotocin- induced diabetes, ß-cells fail to 
synthesis insulin resulting in accumulation of blood 
glucose instead of being utilized or stored. The decline 
in insulin levels observed in this study was reported by 
several previous studies [1, 20]. 
Table 2: Blood Glucose, Insulin and Insulin Resistance Levels in Different Studied Groups 
        Parameters 
Groups 
Glucose 
(mg/dl) 
Insulin 
(µIU/ml) 
Insulin Resistance 
(mgdl-1 µIU ml -1 ) 
Control 74.60 ± 4.1 11.43 ± 0.9 2. 10 ± 0.1 
Flaxseed oil 75.33 ± 2.7b 11.65 ± 1.6 2.16 ± 0.1b 
Diabetic 234.12 ± 9.3a 9.31 ± 1.0 a 5.38 ± 0.2 a 
Treated 162.00 ± 5.1 a,b 10.94 ± 2.0 4.37 ± 0.1a, b 
Data represents ± SE 
Significant P value ≤ 0.05 
a: Significant difference compared to control group 
b: Significant difference compared to diabetic group 
Number of cases = 10 
 Table 3: Oxidant / Antioxidant Parameters in Different 
Studied Groups 
         Parameters 
 Groups 
MDA 
(nmol/g. Tissue) 
SOD 
(U/g. Tissue) 
Control 31.90 ±0.15 453.5±2.1 
Flaxseed oil 30.65 ±0.19
b
 467.7±2.5
b
 
Diabetic 54.43 ±0.20
a
 246.0±1.8
a 
Treated 40.11 ±0.17
a,b
 382.5±1.9
a,b
 
Data represents ± SE  
Significant P value ≤ 0.05 
a: Significant difference compared to control group 
b: Significant difference compared to diabetic group 
Number of cases = 10 
Table 4: Nitric Oxide and ADMA Levels in Different 
Studied Groups 
       Parameters 
Groups 
NO 
(µmol/L) 
ADMA 
(µmol/L) 
Control 131.5 ±1.3 0.39 ± 0.08 
Flaxseed oil 133.2 ±1.7
 b
 0.36 ± 0.07
 b
 
Diabetic 82.9 ± 1.2
 a
 1.43 ± 0.12
 a
 
Treated 119.5 ± 1.6
 a, b
 0.88 ± 0.09
 a, b
 
Data represents ± SE  
Significant P value ≤ 0.05 
a :Significant difference compared to control group 
b :Significant difference compared to diabetic group 
Number of cases = 10 
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STZ also has the ability to increase oxidative stress 
as was found in our study by elevation of liver MDA 
and the reduction of antioxidant enzyme (SOD) activity. 
One from the most relevant pathogenic factors of 
complications in diabetes is increased oxidative stress 
[21]. Generally oxidative damage is a resultant to the 
production of highly reactive hydroxyl radical, which 
causes major oxidative damage to the cell's 
components like proteins, DNA and lipids [22].  
Endothelial dysfunction is one of the important 
diabetic complications. In the current study, we found 
an elevation of ADMA level and a reduction in NO level 
in diabetic group compared to control group.  
Several studies indicated that ADMA has been used 
as an important marker of endothelial dysfunction. 
There is a proof that elevation of ADMA level may be a 
cause or a result of rising insulin resistance [23]. 
Surprisingly, several investigations indicated that 
insulin resistance plays an indicative role in 
propagation and proliferation of diabetic complications 
and retinopathy [24]. However, different studies 
indicated that increased ADMA level is an important 
factor in diabetic complications and retinopathy; these 
evidences reflect a phenomenon of the association of 
diabetic complication with both ADMA elevation and 
insulin resistance [25]. 
In this study flaxseed oil administration significantly 
decreased blood glucose as well as insulin resistance 
in treated group compared to diabetic one. Flaxseed oil 
as a source of omega-3 fatty acids (mainly α-linolenic 
acid) enhanced omega 3 fatty acids to compete with 
omega-6 family for incorporation into cell membrane 
[26, 27] resulting in a reduction of arachidonic acid 
(omega-6) liberation from the cell membrane. 
The reduction of arachidonic acid lead to a 
reduction of reactive oxygen species (ROS) and 
increasing antioxidant enzymes as was found in our 
work. Thus, in this study flaxseed oil administration 
significantly increased SOD activity and decreased 
MDA level. 
Our previous works indicated the beneficial effect of 
flaxseed oil supplementation in reducing insulin 
resistance in treated group compared to diabetic one 
[1, 28].  
In the same line, Kato et al. [29] indicated that 
GLUT-4 in mice treated with α- linolenic acid was 
significantly elevated compared to control group. In 
addition, Pifferi et al. [30] reported that endothelial Glut-
1 significantly reduced in microvessels deficient in n-3 
PUFA when compared to control group, while this 
value was elevated in the microvessels of rats fed the 
high n-3 polyunsaturated fatty acid diet. The study 
suggested that n-3 PUFA can improve glucose 
transport in the brain in endothelial cells of the blood-
brain barrier, possibly via the protein expression 
changes in Glut-1. 
Supplementation of flaxseed oil in this study slightly 
increased insulin level in treated group compared to 
diabetic group (Table 2); thus it stimulates high 
secretion of insulin from β-cells; whereas insulin has 
vasodilatory properties, as well as anti-inflammatory 
effects [31]. Insulin action in insulin responsive tissues 
is being mediated by the insulin signaling cascade and 
stimulates generation of nitric oxide in skeletal muscle 
and vascular smooth muscle. 
In addition, anti-oxidant protection of flaxseed oil 
elicited decreased cellular production and release of 
oxygen radicals in the vascular wall, inhibits endothelial 
activation of oxidation-sensitive genes, and improves 
the biologic activity of NO through a cell- or tissue-
specific antioxidant action. [32] 
In conclusion, flaxseed oil serves as a promising 
agent that effectively attenuates hyperglycemia in 
experimental diabetes through its antioxidant and anti-
inflammatory effects beside its role in attenuation of 
endothelial dysfunction that appeared through ADMA 
and NO estimation. 
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